IMMUNOCHEMISTRY PROFILES Dr. Thomas Williams. TESTS DISEASES CASES.

Slides:



Advertisements
Similar presentations
Electrophoresis and its Application for diagnosis
Advertisements

MGUS (interpreting the test you didnt order) Family Medicine Review Course 2011 Christian Cable, MD, FACP.
High Resolution Protein Electrophoresis
Serum Electrophoresis AND IMMUNOFIXATION june 2013 Dr. Nitin A Inamdar Department of Biochemistry Tata Memorial Center
Tabuk University 1 3 rd Year – Level 5 – AY Faculty of Applied Medical Sciences Department Of Medical Lab. Technology.
Serum Protein Electrophoresis
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Dr A. Mousavi.  15 % of all malignant white cell diseases  1% of all cancer deaths  Group of lymphoid neoplasms of terminally differentiated B-cells.
Chapter 21 Monoclonal Gammopathies
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications.
CLS 404 Immunology Protein Abnormalities
Diagnosis of Paraprotein Diseases CLS 404 Immunology Protein Abnormalities.
Waldenström’s Macroglobulinemia And the Hyperviscosity Syndromes.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Hyperimmunoglobulinemia Abnormally high blood levels of immunoglobulins. Abnormally high blood levels of immunoglobulins. Polyclonal immunoglobulins Polyclonal.
FAST TRACK REFERRALS Haematology Dr.V Tandon Consultant Haematologist
Week 11: Lymphoproliferative Disorders Multiple myeloma Multiple myeloma Plasma cell Plasma cell Monoclonal gammopathy Monoclonal gammopathy Bence-Jones.
Waldenstrom’s Macroglobulinemia
Terry Kotrla, MS, MT(ASCP)BB Topic 3 Autoimmunity Part 8 Immunoproliferative Diseases.
Practical training A1 Serum protein electrophoresis Pavla Balínová
Electrophoresis Principle:
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
MULTIPLE MYELOMA (MM).
Understanding Your Blood Work
Diagnostic Hematology: Disorders of Hemoglobin and Gammopathies Muhammad Shoaib Khan GM Centre - 1.
Director of Scientific Affairs
Multiple Myeloma Definition:
Clinical interpretation of Serum Free Light Chain assays 22 Feb 2013 Dr. Eric Chan Consultant Immunologist Queen Mary Hospital Hong Kong.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
Multiple Myeloma Definition:
Epidemiology 12,000 deaths in United States per year
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Plasma Proteins.
LYMPHOPROLIFERATIVE DISORDERS
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
MLAB 1415: H EMATOLOGY K ERI B ROPHY -M ARTINEZ Chapter 26: Lymphoid Malignancies Part Two.
Biological functions transport –albumin –transferin –ceruloplasmin –haptoglobin oncotic pressure regulation coagulation immunity.
Clinical diagnostic biochemistry - 5 Dr. Maha Al-Sedik 2015 CLS 334.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Chicago Medical School
Myeloproliferative Lymphoproliferative & Immunoproliferative disorders.
Dr Samal Nauhria .edu Plasma cell lesions Dr Samal Nauhria .edu.
 Serum protein electrophoresis is an easy method of separating serum proteins based on their net charge, size, and shape.  A small amount of serum is.
Plasma cell Dyscrasia 1- B.M.G. 2- Multiple Myeloma 3- Waldenstrom Macroglubolenemia 4- Heavy Chain disease 5- Amyloidosis.
Plasma Cell Dyscrasis Sanambar Sadighi Hematologist-Oncologist Cancer Institute.
Serum Protein Electrophoresis (SPEP)
M. Multiple Myeloma Malignant proliferation of plasma cells. Malignant proliferation of plasma cells. Normal plasma cell form Ig which contain heavy and.
Para-proteinaemias Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor 7 th march 2016.
May 13, 2016 Dr Sindu Kanjeekal MD FRCPC
CONCEPT MAP CONCEPT MAP. 42 y/o male, CC: EDEMA ON BILATERAL EXTREMITIES. Diagnosed with a benign cystic lesion 8 yrs ago S/Sx: BONE PAINS, EASY FATIGUABILITY.
Case Study Multiple Myeloma.
Miten R. Patel, MD Cancer Specialists of North Florida
Paraproteinaemias. Multiple myeloma. Amyloidosis. Part 2 Dr
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez
MULTIPLE MYELOMA (MM) objective: definition of MM Biochemical investigation in Diagnosis.
SERUM OR PLASMA TOTAL PROTEIN
MLAB Hematology Keri Brophy-Martinez
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
MLAB Hematology Fall 2007 Keri Brophy-Martinez
History: 33 y/o woman with decreased vision in left eye
Section III Physiological Biochemistry Universities Press
Multiple myeloma (MM) & related disorders
immunoglobinopathies
PARAPRTEINAEMIA and MULTIPLE MYELOMA
Bence Jones protein The Bence Jones protein was described by the English physician Henry Bence Jones in 1847 and published in 1848.Henry Bence Jones The.
Presentation transcript:

IMMUNOCHEMISTRY PROFILES Dr. Thomas Williams

TESTS DISEASES CASES

PARAPROTEIN MONOCLONAL PROTEIN M PROTEIN PROTEIN SPIKE M SPIKE

TESTS

Serum Protein Electrophoresis: Uses Protein Profile 1.General Medical Diseases 2.Defect Dysproteinemias 3.Humoral Immunodeficiency 4.Paraprotein Detection

Quantitative Assays: Uses 1.Confirm protein abnormalities suspected by serum protein electrophoresis 2.Monitor or follow known conditions 3.Confirm clinically suspected conditions 4.Identify paraproteins noted by electrophoresis 5.Says “Nothing” about monoclonality of immunoglobulins measured

Immunofixational Electrophoresis/ Immunoelectrophoresis: Qualitatively Identifies Proteins Paraproteins: Heavy and light chains Other proteins

Diseases – General Medical (Non-Paraprotein Associated)

Acute Phase Reactants  Haptoglobin Alpha, -Antitrypsin Alpha, -Acid Glycoprotein C-Reactive Protein C3 Ceruloplasmin  Albumin Transferrin Prealbumin

Selective Deficiencies Must Do Quantitative Assays

Diseases: Paraprotein Associated

MGUS

Multiple Myeloma

> 2 g/dL spike (or 3 g/dL) < Normal Immunoglobulins 5-10% or > Marrow plasma cells Bone lesions Anemia Other

Waldenstrom’s Macroglobulinemia

IgM Monoclonal Gammopathy (“Macroglobulinemia of Waldenstrom”) 80%:Fatigue, weakness, weight loss, lymphadenopathy, hepatosplenomegaly. Lymphocytes, plasmacytoid lymphocytes, plasma cells, admixed large cells. 1 in 10 develops localized or terminal disseminated large cell lymphoma. 10%:CLL with or without appreciable plasmacytoid features. 10%:Classic multiple myeloma with neoplastic plasma cells predominating.

IgM Monoclonal Gammopathy (“Macroglobulinemia of Waldenstrom”) Common to all:  Reduced levels of other Ig classes.  + bleeding diathesis, + visual disturbances and ocular abnormalities  + cold agglutinins (Raynaud’s syndrome, pupura), + hyperviscosity  B-J proteinuria usually at low level. Amyloidosis < 10%

Hyperviscosity Syndrome Symptoms include chronic nasal bleeding and oozing from the gums, blurring or loss of vision, dizziness, headaches, vertigo Most patients have symptoms when the relative serum viscosity reaches 6 or 7 (normal less than 1.8)

Hyperviscosity Syndrome Continued Most common causes of hyperviscosity syndrome are macroglobulinemia of Waldenstrom and IgA myeloma Treatment consists of plasmapheresis

Alpha, Mu, Gamma Heavy Chain Disease

Cases

Serum MG Evaluation SPE + IEP SPE + IFE SPE + QUANT Ig (WITH K/L) +/- IFE/IEP QUANT Ig WITH K/L OTHER